Cargando…

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

BACKGROUND: Although statins reduce cardiovascular events, residual risk remains. Therefore, additional modalities are needed to reduce risk. We evaluated the effect of eicosapentaenoic acid and docosahexaenoic acid in pharmacologic doses added to statin treatment on coronary artery plaque volume. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfaddagh, Abdulhamied, Elajami, Tarec K., Ashfaque, Hasan, Saleh, Mohamad, Bistrian, Bruce R., Welty, Francine K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779017/ https://www.ncbi.nlm.nih.gov/pubmed/29246960 http://dx.doi.org/10.1161/JAHA.117.006981

Ejemplares similares

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
por: Elajami, Tarec K., et al.
Publicado: (2017)

Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease
por: Welty, Francine K., et al.
Publicado: (2023)

The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC
por: Maniar, Yash, et al.
Publicado: (2022)

Exercise Capacity, Coronary Artery Fatty Plaque, Coronary Calcium Score, and Cardiovascular Events in Subjects With Stable Coronary Artery Disease
por: Malik, Abdulaziz, et al.
Publicado: (2020)

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2019)

Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins
por: Kato, Yuta, et al.
Publicado: (2018)

Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats
por: Boivin, Alexandra, et al.
Publicado: (2017)

Role of Statins in Coronary Artery Disease
por: Lim, Sang Yup
Publicado: (2013)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
por: Russell, Fraser D., et al.
Publicado: (2012)

Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome
por: Yagi, Shusuke, et al.
Publicado: (2015)

The Effects of Statin and Niacin on Plaque Stability, Plaque Regression, Inflammation and Oxidative Stress in Patients With Mild to Moderate Coronary Artery Stenosis
por: Lee, Kyounghoon, et al.
Publicado: (2011)

Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease
por: Yagi, Shusuke, et al.
Publicado: (2014)

Serum Eicosapentaenoic and Arachidonic Acids Concentration and Cognitive Function in Patients With Coronary Artery Disease
por: Yoosefee, Sadegh, et al.
Publicado: (2021)

Erratum to: ‘Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome’
por: Yagi, Shusuke, et al.
Publicado: (2015)

Added Value of Computed Tomography Virtual Intravascular Endoscopy in the Evaluation of Coronary Arteries with Stents or Plaques
por: Wu, Patricia Wanping, et al.
Publicado: (2022)

The effect of statin therapy on the characteristics of coronary artery disease in patients with acute coronary syndrome
por: Gulin, D, et al.
Publicado: (2013)

Coronary plaque tissue characterization in patients with premature coronary artery disease
por: Xie, Jianchang, et al.
Publicado: (2020)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease
por: Widlansky, Michael E., et al.
Publicado: (2023)

Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
por: Cerit, L., et al.
Publicado: (2016)

Sex disparities in the presentation, management and outcomes of patients with acute coronary syndrome: insights from the ACS QUIK trial
por: Khraishah, Haitham, et al.
Publicado: (2021)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
por: Bate, Clive, et al.
Publicado: (2008)

Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque Burden
por: Christiansen, Morten Krogh, et al.
Publicado: (2020)

Molecular imaging of plaques in coronary arteries with PET and SPECT
por: Sun, Zhong-Hua, et al.
Publicado: (2014)

The site-specific distribution of atheromatous plaques in the coronary arteries
por: Wasilewski, Jarosław, et al.
Publicado: (2023)

Comparison of coronary arterial lumen dimensions on angiography and plaque characteristics on optical coherence tomography images and their changes induced by statin
por: Dong, Nana, et al.
Publicado: (2016)

Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function
por: Driscoll, David F., et al.
Publicado: (2023)

Investigating potential mediator between statin and coronary artery calcification
por: Lee, Donghun, et al.
Publicado: (2018)

Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease
por: Premnath, Sujatha Mahadevarao, et al.
Publicado: (2023)

Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial
por: Nakao, Kazuhiro, et al.
Publicado: (2018)

Sex Differences in Associations of Arterial Compliance With Coronary Artery Plaque and Calcification Burden
por: Coutinho, Thais, et al.
Publicado: (2017)

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease
por: Bom, Michiel J., et al.
Publicado: (2018)

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
por: Siddiqui, Rafat A, et al.
Publicado: (2005)

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
por: Ochi, Eisuke, et al.
Publicado: (2018)

Mechanisms of BK Channel Activation by Docosahexaenoic Acid in Rat Coronary Arterial Smooth Muscle Cells
por: Qian, Ling-Ling, et al.
Publicado: (2018)

Angioscopic Evaluation of Stabilizing Effects of Bezafibrate on Coronary Plaques in Patients With Coronary Artery Disease
por: Uchida, Yasumi, et al.
Publicado: (2000)

Prevalence of coronary atherosclerotic plaque in patients with a low coronary artery calcium score
por: Mehta, VS, et al.
Publicado: (2012)

Prevalence of noncalcified plaques and coronary artery stenosis in patients with coronary calcium scores of zero
por: Al-Muhaidb, Saud M., et al.
Publicado: (2020)

Non-mercaptalbumin is significantly associated with the coronary plaque burden and the severity of coronary artery disease
por: Chou, Shengpu, et al.
Publicado: (2021)

Non-Calcified Coronary Artery Plaque on Coronary Computed Tomography Angiogram: Prevalence and Significance
por: Alyami, Bandar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4sog6vdqflnacji4fv1ggh65ub